(Q34452109)

2 August 2017

1 reference

title

Lentivirus and foamy virus vectors: novel gene therapy tools (English)

1 reference

2 August 2017

0 references

0 references

Pandya S

1

1 reference

2 August 2017

Klimatcheva E

series ordinal

2

1 reference

2 August 2017

Planelles V

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Expert Opinion on Biological Therapy

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

17-40

1 reference

Cancer gene therapy: connecting basic research with clinical inquiry

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Applications of gene therapy to the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Gene-modified cells for the treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Vector problems still thwart gene-therapy promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Lentiviral vectors--the promise of gene therapy within reach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Viral vectors, tools for gene transfer in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Cell cycle dependence of synthesis of unintegrated viral DNA in mouse cells newly infected with murine leukemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

HIV-1: fifteen proteins and an RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

The activation domain of simian immunodeficiency virus SIVmac239 Rev protein is structurally and functionally analogous to the HIV-1 Rev activation domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Functional analysis of vif genes derived from various primate immunodeficiency viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

The requirement for Vif of SIVmac is cell-type dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Importance of the nef gene for maintenance of high virus loads and for development of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

The role of the chemokine receptor CXCR4 in infection with feline immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

HIV infection does not require endocytosis of its receptor, CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Mechanism of formation of pseudotypes between vesicular stomatitis virus and murine leukemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Properties of human foamy virus relevant to its development as a vector for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Foamy virus vectors for suicide gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Gene transfer using replication-defective human foamy virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Nucleocytoplasmic transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Retrovirus-mediated transfer and expression of drug resistance genes in human haematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Progress in transcriptionally targeted and regulatable vectors for genetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

A promoterless retroviral vector indicates that there are sequences in U3 required for 3' RNA processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Self-inactivating lentiviral vectors with U3 and U5 modifications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Lentiviral vectors: regulated gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

A generic intron increases gene expression in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Retrovirus vector silencing is de novo methylase independent and marked by a repressive histone code

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Development of a novel trans-lentiviral vector that affords predictable safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

The 5' RNA terminus of spleen necrosis virus stimulates translation of nonviral mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Production and concentration of pseudotyped HIV-1-based gene transfer vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Metabolic biotinylation of recombinant proteins in mammalian cells and in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Regulated lentiviral packaging cell line devoid of most viral cis-acting sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Development of novel simian immunodeficiency virus vectors carrying a dual gene expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Targeting retroviral integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Central core domain of retroviral integrase is responsible for target site selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Human immunodeficiency virus type 2 lentivirus vectors for gene transfer: expression and potential for helper virus-free packaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Development of HIV vectors for anti-HIV gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Stable gene transfer to the nervous system using a non-primate lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Simian foamy virus type 1 contains a second promoter located at the 3' end of the env gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Lentiviral vectors for gene therapy of cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Antisense RNA sequences targeting the 5' leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Gene therapeutic agents: the use of ribozymes, antisense, and RNA decoys for HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Preclinical characterization of an anti-tat ribozyme for therapeutic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

How is the Human Genome Project doing, and what have we learned so far?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

Slow Virus Replication: the Role of Macrophages in the Persistence and Expression of Visna Viruses of Sheep and Goats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.1.17

21 January 2018

Identifiers

DOI

10.1517/14712598.1.1.17

1 reference

2 August 2017

1 reference